Evidence map›Paper›PMID 39434129›Full record

ArticleBMC urology2024

Outcomes of laparoscopic, robotic and open nephroureterectomy with bladder cuff excision in patients with T3T4 upper urinary tract urothelial carcinoma: a multi-center retrospective study.

Jen-Kai Fang, Hsin-Chih Yeh, Hsiang-Ying Lee, Han-Yu Weng, Ta-Yao Tai, Chao-Yuan Huang, Jian-Hua Hong, Chih-Chin Yu, Shu-Yu Wu, Shiu-Dong Chung and 19 more

Abstract readMulticenter StudyComparative Study
In one paragraph

Article in BMC urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Jen-Kai FangDepartment of Urology, China Medical University Hospital, China Medical university, Taichung, Taiwan.
Hsin-Chih YehDepartment of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
Hsiang-Ying LeeDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Han-Yu WengDepartment of Urology, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan.
Ta-Yao TaiDepartment of Urology, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan.
Chao-Yuan HuangDepartment of Urology, College of Medicine, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
Jian-Hua HongDepartment of Urology, College of Medicine, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
Chih-Chin YuDivision of Urology, Department of Surgery, Taipei Tzuchi Hospital, The Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
Shu-Yu WuDivision of Urology, Department of Surgery, Taipei Tzuchi Hospital, The Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
Shiu-Dong ChungSleep Research Center, Taipei Medical University Hospital, Taipei, Taiwan.
Chung-You TsaiDivision of Urology, Department of Surgery, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
Thomas Y HsuehDivision of Urology, Department of Surgery, Taipei City Hospital Renai Branch, Taipei, Taiwan.
Allen W ChiuDepartment of Urology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Yuan-Hong JiangDepartment of Urology, School of Medicine, Buddhist Tzu Chi University, Hualien, Taiwan.
Yu KhunDepartment of Urology, China Medical University Hospital, China Medical university, Taichung, Taiwan.
LeeDepartment of Urology, School of Medicine, Buddhist Tzu Chi University, Hualien, Taiwan.
I-Hsuan Alan ChenDivision of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Jen-Tai LinDivision of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Yung-Tai ChenDepartment of Urology, College of Medicine, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
Chang-Min LinDepartment of Urology, Taiwan Adventist Hospital, Taipei, Taiwan.
Ian-Seng CheongDepartment of Urology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi, 600, Taiwan.
Hsu-Che HuangDivision of Urology, Department of Surgery, Cardinal Tien Hospital, New Taipei City, 23148, Taiwan.
Shih-Hsiu LoDepartment of Urology, Taipei Medical University Hospital, Taipei Medical University, Taipei City, Taiwan.
Wei-Yu LinDivision of Urology, Department of Surgery, Chang Gung Memorial Hospital, Chia-Yi, Taiwan.
Jen-Shu TsengDepartment of Urology, MacKay Memorial Hospital, Taipei, Taiwan.
Chia-Chang WuDepartment of Urology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
Shian-Shiang WangDivision of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.
Yi-Huei ChangDepartment of Urology, China Medical University Hospital, China Medical university, Taichung, Taiwan.
Chao-Hsiang ChangDepartment of Urology, China Medical University Hospital, China Medical university, Taichung, Taiwan. urology8395@yahoo.com.tw.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNephroureterectomy with bladder cuff excision is the standard treatment for high-risk upper urinary tract urothelial carcinoma (UTUC). The role of minimally invasive surgery in treating locally advanced UTUC remains controversial. This study aimed to compare the outcomes of open, laparoscopic, and robotic surgeries for managing locally advanced UTUC.

methodsWe retrospectively reviewed 705 patients with locally advanced UTUC from multiple institutions throughout Taiwan. Perioperative outcomes and oncological outcomes, such as cancer-specific survival, overall survival, disease-free survival and bladder-free survival, were compared between the open, laparoscopic and robotic groups.

resultsThe minimally invasive group had better overall and cancer-specific survival (CSS) rates. The 2-year CSS rates of the open, laparoscopic and robotic groups were 71%, 83%, and 77% respectively (p < 0.001). The robotic group had similar outcomes to the laparoscopic group. (p = 0.061, 0.825, 0.341 for OS, CSS, DFS respectively.) More lymph node dissections were performed and more lymph nodes were harvested in the robotic group (p = 0.009).

conclusionsOur results demonstrated that minimally invasive surgery, including laparoscopic and robotic surgery, for locally advanced UTUC resulted in oncological outcomes that are non-inferior to those of open surgery.

Indexed as

Carcinoma, Transitional CellKidney NeoplasmsLaparoscopyNephroureterectomyRobotic Surgical ProceduresUreteral NeoplasmsAgedAged, 80 and overFemaleHumansMaleMiddle AgedNeoplasm StagingRetrospective StudiesTreatment OutcomeUrinary BladderMinimally invasive surgeryRobotic surgeryUpper tract urothelial carcinoma

Identifiers

PMID39434129
PMCPMC11492713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.